IK
Indira Kattabelthur Sulse
About Indira Kattabelthur Sulse
Data last updated:
Indira Kattabelthur Sulse is a Director at Deleton Lifesciences Private Limited (since 2021) and Partner at Aaryapatha Pharma Llp (since 2020). The companies operate in Food And Beverages and Home Appliances. The largest current company by reported revenue is Deleton Lifesciences Private Limited at ₹39 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Apr 2021 | 2017 | ₹39 Lakh (FY 2021) | Active | |
| Partner | 25 Nov 2020 | 2020 | Active |
Board colleagues of Indira Kattabelthur Sulse
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manyam Venkatesh | 07976051 | Deleton Lifesciences Private Limited | Director |
| Shilpa Chaitanya Reddy Kudumula | 08970328 | Deleton Lifesciences Private Limited , Aaryapatha Pharma Llp | Director |
| Keathineni Dinesh | 07976041 | Aaryapatha Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Indira Kattabelthur Sulse
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indira Kattabelthur Sulse
Indira Kattabelthur Sulse currently holds 2 directorships: Deleton Lifesciences Private Limited (Director, since 06 Apr 2021, revenue ₹39 Lakh (FY 2021)); Aaryapatha Pharma Llp (Partner, since 25 Nov 2020).
Indira Kattabelthur Sulse was first appointed on 25 Nov 2020 as Partner at Aaryapatha Pharma Llp. The most recent appointment on record is 06 Apr 2021 at Deleton Lifesciences Private Limited.
The current boards of Indira Kattabelthur Sulse's companies include Manyam Venkatesh (Deleton Lifesciences Private Limited), Shilpa Chaitanya Reddy Kudumula (Deleton Lifesciences Private Limited), Keathineni Dinesh (Aaryapatha Pharma Llp).